Eligibility Pre-Screening

A Study of LX107 Gene Therapy in AIPL1-IRD Patients

This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.

Question 1 of 60%

1.Have you (or the patient) been diagnosed with an inherited retinal disease caused by mutations in the AIPL1 gene (AIPL1-IRD)?

Press Y/N or 1/2